Supramolecular Motion Enables Chondrogenic Bioactivity of a Cyclic Peptide Mimetic of Transforming Growth Factor-β1

J Am Chem Soc. 2024 Aug 7;146(31):21555-21567. doi: 10.1021/jacs.4c05170. Epub 2024 Jul 25.

Abstract

Transforming growth factor (TGF)-β1 is a multifunctional protein that is essential in many cellular processes that include fibrosis, inflammation, chondrogenesis, and cartilage repair. In particular, cartilage repair is important to avoid physical disability since this tissue does not have the inherent capacity to regenerate beyond full development. We report here on supramolecular coassemblies of two peptide amphiphile molecules, one containing a TGF-β1 mimetic peptide, and another which is one of two constitutional isomers lacking bioactivity. Using human articular chondrocytes, we investigated the bioactivity of the supramolecular copolymers of each isomer displaying either the previously reported linear form of the mimetic peptide or a novel cyclic analogue. Based on fluorescence depolarization and 1H NMR spin-lattice relaxation times, we found that coassemblies containing the cyclic compound and the most dynamic isomer exhibited the highest intracellular TGF-β1 signaling and gene expression of cartilage extracellular matrix components. We conclude that control of supramolecular motion is emerging as an important factor in the binding of synthetic molecules to receptors that can be tuned through chemical structure.

MeSH terms

  • Chondrocytes* / cytology
  • Chondrocytes* / drug effects
  • Chondrocytes* / metabolism
  • Chondrogenesis* / drug effects
  • Humans
  • Peptides, Cyclic* / chemical synthesis
  • Peptides, Cyclic* / chemistry
  • Peptides, Cyclic* / pharmacology
  • Transforming Growth Factor beta1* / chemistry
  • Transforming Growth Factor beta1* / metabolism
  • Transforming Growth Factor beta1* / pharmacology

Substances

  • Transforming Growth Factor beta1
  • Peptides, Cyclic